Hans K. Ghayee

North Florida/South Georgia Veterans Health System

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 18 papers. Top paper: “Clinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline SDHD pathogenic variants”.

Clinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline SDHD pathogenic variants

The Lancet Diabetes & Endocrinology(2023)10.1016/s2213-8587(23)00038-4

N/A

1.8DataRank · unranked

88 citations

George B. Wanna, Maleeha Ahmad, Charlotte Lussey‐Lepoutre, Nancy D. Perrier, Svenja Nölting +37 more

Management of phaeochromocytoma and paraganglioma in patients with germline SDHB pathogenic variants: an international expert Consensus statement

Nature Reviews Endocrinology(2023)10.1038/s41574-023-00926-0

N/A

1.6DataRank · unranked

91 citations

Svenja Nölting, Nancy D. Perrier, Martin Fassnacht, Jorge A. Carrasquillo, Ashley Grossman +40 more

Targeting NRF2-Governed Glutathione Synthesis for SDHB-Mutated Pheochromocytoma and Paraganglioma

Cancers(2020)10.3390/cancers12020280

N/A

1.1DataRank · unranked

43 citations

Ying Pang, Veronika Caisová, Jianyi Ding, Di Yu, Yiqiang Zhou +5 more

Targeting pheochromocytoma/paraganglioma with polyamine inhibitors

Metabolism(2020)10.1016/j.metabol.2020.154297

N/A

0.470DataRank · unranked

22 citations

Fernando Bril, Heather Hatch, Yiling Xu, Laura M. Shelton, Srilaxmi Kalavalapalli +34 more

Multi-omic analysis of SDHB-deficient pheochromocytomas and paragangliomas identifies metastasis and treatment-related molecular profiles

Research Square(2024)10.21203/rs.3.rs-4410500/v1

N/A

0.284DataRank · unranked

4 citations

Aidan Flynn, Andrew Pattison, Shiva Balachander, Emma Boehm, Blake Bowen +29 more

Germline SUCLG2 Variants in Patients With Pheochromocytoma and Paraganglioma

JNCI Journal of the National Cancer Institute(2021)10.1093/jnci/djab158

N/A

0DataRank · unranked

35 citations

Ying Pang, Linda Krobova, Michal Kraus, Zuzana Nahácka, Štěpána Boukalová +23 more

Case report: Two sisters with a germline CHEK2 variant and distinct endocrine neoplasias

Frontiers in Endocrinology(2022)10.3389/fendo.2022.1024108

N/A

0DataRank · unranked

9 citations

Yanli Ding, Kimmo J. Hatanpaa, Justin A. Bishop, Sasan Mirfakhraee, Abdel A. Alli +8 more

Genetic impairment of succinate metabolism disrupts bioenergetic sensing in adrenal neuroendocrine cancer

Cell Reports(2022)10.1016/j.celrep.2022.111218

N/A

0DataRank · unranked

16 citations

Keehn Strange, Rahul Telange, Ailan Guo, Heather Hatch, Amin Sobh +16 more

Disordered-to-ordered transitions in assembly factors allow the Complex II catalytic subunit to switch binding partners

Research Square(2022)10.21203/rs.3.rs-2070392/v1

N/A

0DataRank · unranked

1 citations

Elena Maklashina, Markus Voehler, Sona Balintova, Sarka Dvorakova, Michal Kraus +12 more

Phosphoprotein-based biomarkers as predictors for cancer therapy

Proceedings of the National Academy of Sciences(2020)10.1073/pnas.2010103117

N/A

0DataRank · unranked

39 citations

Chunfeng Tan, Karine Pozo, Rahul Telange, Roberto Molinaro, Ailan Guo +24 more

Metabolomics in paraganglioma: applications and perspectives from genetics to therapy

Endocrine Related Cancer(2023)10.1530/erc-22-0376

N/A

0DataRank · unranked

14 citations

Timothy J. Garrett, Nicole Bechmann, Roderick Clifton‐Bligh, Hans K. Ghayee, Susan Richter

Disordered-to-ordered transitions in assembly factors allow the complex II catalytic subunit to switch binding partners

Nature Communications(2024)10.1038/s41467-023-44563-7

N/A

0DataRank · unranked

9 citations

Elena Maklashina, Markus Voehler, Sona Balintova, Sarka Dvorakova, Michal Kraus +13 more

Clinical and Radiological Features of Atypical Adrenal Masses—A Multicenter Retrospective Study

The Journal of Clinical Endocrinology & Metabolism(2024)10.1210/clinem/dgae781

N/A

0DataRank · unranked

3 citations

Ruaa Al-Ward, Katja Kiseljak‐Vassiliades, Lauren Fishbein, Danielle Dawes, Oksana Hamidi +10 more

Some patients with type 2 diabetes may benefit from intensive glycaemic and blood pressure control: A post‐hoc machine learning analysis of ACCORD trial data

Diabetes Obesity and Metabolism(2024)10.1111/dom.15453

N/A

0DataRank · unranked

2 citations

Hamed Kianmehr, Yilu Lin, Piaopiao Li, Naykky Singh Ospina, Hans K. Ghayee +6 more

Niche for polyamine inhibition in treatment of metastatic pheochromocytoma and paraganglioma

European Journal of Clinical Investigation(2024)10.1111/eci.14162

N/A

0DataRank · unranked

1 citations

Heather Hatch, Raymond J. Bergeron, Katerina Hadrava Vanova, Karel Pacák, Sergei G. Tevosian +1 more

Therapeutic Targeting of SDHB -Mutated Pheochromocytoma/Paraganglioma with Pharmacologic Ascorbic Acid

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-2335

N/A

0DataRank · unranked

44 citations

Ying Pang, Boqun Zhu, Ondřej Uher, Veronika Caisová, Thanh‐Truc Huynh +8 more

Development of succinate dehydrogenase subunit B-deficient tumor models for preclinical immunotherapy testing

Cancer Letters(2025)10.1016/j.canlet.2025.217969

N/A

0DataRank · unranked

2 citations

Ondřej Uher, Michal Kraus, Sona Miklovicova, Kateřina Hönigová, Stanislaw Gwiezdzinski +9 more

Succinate Mediates Tumorigenic Effects via Succinate Receptor 1: Potential for New Targeted Treatment Strategies in Succinate Dehydrogenase Deficient Paragangliomas

Frontiers in Endocrinology(2021)10.3389/fendo.2021.589451

N/A

0DataRank · unranked

45 citations

Katerina Hadrava Vanova, Nicole Bechmann, Susan Richter, Julica Folberth, Hans K. Ghayee +16 more